Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
about
Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral PalsyNew clinical and research trends in lower extremity management for ambulatory children with cerebral palsyEffectiveness and safety of botulinum toxin type a in children with musculoskeletal conditions: what is the current state of evidence?Botulinum toxin in children with cerebral palsy.Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity.Increasing physical function through physiatric intervention for children with paediatric neurotransmitter disorders.Children with cerebral palsy: a systematic review and meta-analysis on gait and electrical stimulation.Botulinum toxin A (Dysport®): in dystonias and focal spasticity.Long-lasting paracrine effects of human cord blood cells on damaged neocortex in an animal model of cerebral palsy.Outcomes of Botulinum Toxin Type A for equinovarus deformity in patients with CVA: A case series.AbobotulinumtoxinA: A Review in Pediatric Lower Limb Spasticity.The extent of intrauterine growth restriction determines the severity of cerebral injury and neurobehavioural deficits in rodentsBotulinum toxin use as an adjunctive modality in a patient with multiple flexor tendon ruptures.Early Intensive Leg Training to Enhance Walking in Children With Perinatal Stroke: Protocol for a Randomized Controlled Trial.A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
P2860
Q28074809-B8B62A62-6482-4CC0-91E6-B96C0700BE02Q34302006-B642321B-B45A-4FEB-B6E4-F6BED12EDB73Q35893565-6D2D1D18-561C-4CD6-AC4A-010B42D6B4AEQ35998686-66652001-CD50-436E-838B-758379D1CD05Q36567918-68D1E46B-C708-4412-B19E-153CF594064BQ37486220-87CB6C03-FCC0-4608-8147-91CA8D2D5695Q37777892-C99D198F-3056-4B5A-9319-80F1AB23AB12Q37888668-C25F32C2-7D5A-4B17-9B59-A362DF235BDAQ38463311-B8446D00-4989-4309-99B5-B73B03EC5458Q38686539-A8F46909-35C8-4701-9BF6-D604083D571FQ39379469-7BBA660C-DECE-42DA-B01F-DB7EDC4C9B5FQ42362042-3926D47E-B434-426E-BF29-1ADE96FD30BFQ42418542-B44C8CD0-F4F5-4B2D-9FFB-45BA4DA09002Q47301968-EB01D46E-27BD-4E25-B76F-79B7D2840896Q47687471-5F324933-B62B-476D-B780-319B3D889D41
P2860
Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Spasticity associated with cer ...... the use of botulinum A toxin.
@ast
Spasticity associated with cer ...... the use of botulinum A toxin.
@en
type
label
Spasticity associated with cer ...... the use of botulinum A toxin.
@ast
Spasticity associated with cer ...... the use of botulinum A toxin.
@en
prefLabel
Spasticity associated with cer ...... the use of botulinum A toxin.
@ast
Spasticity associated with cer ...... the use of botulinum A toxin.
@en
P2093
P1433
P1476
Spasticity associated with cer ...... the use of botulinum A toxin.
@en
P2093
Beth Paterson Smith
L Andrew Koman
Rajesh Balkrishnan
P356
10.2165/00128072-200305010-00002
P577
2003-01-01T00:00:00Z
P6179
1052063475